News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
687,277 Results
Type
Article (39651)
Company Profile (303)
Press Release (647323)
Section
Business (206288)
Career Advice (2037)
Deals (35790)
Drug Delivery (81)
Drug Development (81884)
Employer Resources (171)
FDA (16058)
Job Trends (15090)
News (348349)
Policy (32725)
Tag
Academia (2548)
Africa (733)
Alliances (49732)
Alzheimer's disease (1158)
Approvals (15994)
Arizona (171)
Artificial intelligence (68)
Asia (38004)
Australia (6114)
Bankruptcy (353)
Best Places to Work (11344)
Biosimilars (63)
Biotechnology (210)
C2C Services and Suppliers (79056)
California (1671)
Canada (863)
Cancer (340)
Career advice (1694)
Cell therapy (105)
China (123)
Clinical research (63997)
Collaboration (115)
Colorado (66)
Compensation (61)
Connecticut (67)
COVID-19 (2502)
Cystic fibrosis (73)
Data (172)
Diabetes (70)
Diagnostics (5970)
Drug pricing (64)
Earnings (84630)
Employer resources (146)
Europe (81639)
Events (109884)
Executive appointments (114)
FDA (16243)
Florida (231)
Funding (108)
Gene therapy (81)
GLP-1 (524)
Government (4322)
Healthcare (18660)
Hotbed/Location (485482)
Illinois (242)
Indiana (137)
Infectious disease (2526)
Inflammatory bowel disease (88)
Interviews (322)
IPO (16405)
Job creations (3825)
Job search strategy (1456)
Kansas (93)
Layoffs (404)
Legal (7876)
Lung cancer (73)
Manufacturing (77)
Maryland (366)
Massachusetts (1394)
Medical device (13033)
Medtech (13036)
Mergers & acquisitions (19210)
Metabolic disorders (229)
Michigan (118)
Minnesota (208)
Neuroscience (1286)
New Jersey (506)
New York (523)
NextGen Class of 2024 (6536)
Non-profit (4471)
North Carolina (612)
Northern California (751)
Obesity (139)
Ohio (99)
Opinion (184)
Patents (63)
Pennsylvania (541)
People (56577)
Pharmaceutical (75)
Phase I (19861)
Phase II (28247)
Phase III (20993)
Pipeline (99)
Postmarket research (2556)
Preclinical (8444)
Press Release (64)
Rare diseases (117)
Real estate (6001)
Recruiting (65)
Regulatory (21399)
Research institute (2324)
Resumes & cover letters (350)
South America (1109)
Southern California (673)
Startups (3636)
Texas (206)
United States (7855)
Vaccines (462)
Washington State (241)
Weight loss (124)
Date
Today (6)
Last 7 days (583)
Last 30 days (2052)
Last 365 days (37763)
2024 (25426)
2023 (40659)
2022 (51785)
2021 (56342)
2020 (54540)
2019 (46983)
2018 (35387)
2017 (32638)
2016 (32060)
2015 (38110)
2014 (32005)
2013 (26894)
2012 (29013)
2011 (29668)
2010 (27706)
687,277 Results for "therapure biopharma inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
VGXI Inc. announces a strategic partnership with Sutro Biopharma Inc. to support growing clinical pipeline
VGXI, Inc. has entered into a strategic partnership with Sutro Biopharma, Inc. to support clinical production of luveltamab tazevibulin, abbreviated as “luvelta”, a novel Folate Receptor-α -targeting antibody-drug conjugate with the potential to address the unmet need in several FRα-expressing cancers.
June 3, 2024
·
4 min read
Business
Theravance Biopharma, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update
Theravance Biopharma, Inc. (“Theravance Biopharma” or the “Company”) (NASDAQ: TBPH) today announced financial and operational results for the first quarter of 2024.
May 13, 2024
·
17 min read
Biotech Beach
Navigate BioPharma Services, Inc. Launch Assay for Precise Measurement of Radioligand Therapy Response in Tumors
Navigate BioPharma Services, Inc., a specialty laboratory offering high-quality, innovative precision medicine solutions and bioanalytics for clinical development and diagnostic applications, launch a new assay for quantifying pharmacodynamic markers of radioligand therapies in tumors.
May 31, 2024
·
3 min read
Job Trends
Difficult Market Turns More Biopharma Leaders to Fractional Roles, Say Experts
For reasons including downsizing, avoiding retirement and a tight labor market, senior-level biopharma professionals are increasingly turning to fractional roles, according to two recruitment experts.
August 28, 2024
·
4 min read
·
Angela Gabriel
Job Trends
Massachusetts’ Biopharma Jobs Grew at Slowed Rate in 2023: Report
Massachusetts’ biopharma jobs increased 2.6% in 2023, according to the MassBio Industry Snapshot. Whether the state’s jobs grow in 2024 remains to be seen based on this year’s layoffs and seemingly slowed hiring based on
BioSpace
data.
August 27, 2024
·
5 min read
·
Angela Gabriel
Career Advice
The Top 12 Companies Hiring in Biopharma Now
Looking for a biopharma job? Check out the
BioSpace
list of 12 top companies hiring life sciences professionals like you.
September 5, 2024
·
1 min read
·
Angela Gabriel
Biotech Beach
Regen BioPharma, Inc. to Present at the Emerging Growth Conference on May 9, 2024
Regen BioPharma, Inc., a biotechnology company advancing a diverse pre-clinical pipeline spanning cell therapies, RNA vaccines, RNA and DNA therapeutics and small molecule drugs will be presenting at the Emerging Growth Conference on May 9, 2024.
May 7, 2024
·
3 min read
Drug Development
Avirmax Biopharma Inc. Receives IND Approval for Phase I/IIa Trial to Treat Wet AMD including PCV
Avirmax Biopharma, Inc. is pleased to announce that it has received Investigational New Drug (IND) approval from the U.S. Food and Drug Administration (FDA) to initiate a Phase I/IIa clinical trial for its gene therapy treatment targeting wet Age-related Macular Degeneration.
May 30, 2024
·
2 min read
Employer Resources
Embracing Inclusivity: How Biopharmas Connect With LGBTQ+ Employees
There are multiple ways biopharmas create inclusive workplaces for LGBTQ+ employees, and they go beyond employee resource groups and benefits.
June 5, 2024
·
6 min read
·
Angela Gabriel
Deals
Biopharma Investment Activity Continued to Rise in Q2: J.P. Morgan
A report from J.P. Morgan shows an increase in biopharma activity so far this year and where some improvement can be made.
July 31, 2024
·
3 min read
·
Tyler Patchen
1 of 68,728
Next
